Nutrien Ltd. NTR

Nutrien is actively pursuing a focused approach to simplify its portfolio, aiming to enhance earnings quality and free cash flow. This includes the divestiture of noncore assets like equity interests in Sinofert and Profertil, along with smaller assets in South America and Europe, expected to generate approximately $900 million in gross proceeds. The company has also initiated a strategic review of its Phosphate business, evaluating options ranging from reconfiguring operations and strategic partnerships to a potential sale, with conclusions expected in 2026. The Trinidad Nitrogen operations were shut down in October due to port access and gas supply uncertainty, contributing less than 1% of consolidated free cash flow in 2025, with options for long-term financial performance being assessed.

The company demonstrated significant operational progress, increasing fertilizer sales volumes by approximately 750,000 tonnes in the first nine months of 2025. Potash operations achieved record sales volumes in the first nine months and increased the percentage of ore tonnes cut with automation to over 40%, maintaining a low-cost position. Nitrogen operations reached a 94% ammonia utilization rate through the first nine months, a 7 percentage point improvement year-over-year, reflecting successful reliability initiatives. Phosphate operations achieved an 88% operating rate in Q3, benefiting from reliability and turnaround activities completed in the first half.

The Downstream Retail segment delivered 5% higher adjusted EBITDA in the first nine months, driven by expense reduction and proprietary product gross margin growth. Q3 adjusted EBITDA for Retail was $230 million, up 52% from the prior year, supported by strong crop input demand in the U.S. corn belt. The company expects North American crop nutrient volumes to be slightly higher in Q4 with per-tonne margins similar to the prior year. Proprietary products continue to be a strategic growth driver, with significant margin increases in nutritionals and biologicals in Q3, and plans to introduce over 30 new products globally in 2026.

Nutrien is on track to achieve its $200 million cost reduction target one year ahead of schedule, contributing to a 5% reduction in SG&A expenses year-to-date. Capital expenditures were lowered by 10% year-to-date through optimization efforts. The company allocated $1.2 billion to dividends and share repurchases in the first nine months, a 42% increase year-over-year, with share repurchases at a rate of approximately $45 million per month. Proceeds from divestitures are intended for targeted growth investments, share repurchases, and debt reduction, with a goal to meaningfully lower net debt by year-end.

The company holds a constructive outlook, anticipating healthy crop input demand and continued growth in global potash shipments, forecast between 74 million and 77 million tonnes in 2026. This outlook is supported by strong potash affordability, significant soil nutrient removal from a record crop, and low channel inventories in major markets like China (down over 1 million tonnes YoY). Limited new global capacity additions are expected in 2026, with potential industry supply additions from FSU, Canada, and Laos each around 0.5 million tonnes. Global nitrogen supply challenges are expected to maintain a tight supply/demand balance into 2026, with firming urea prices due to seasonal demand and tight ammonia markets from plant outages and project delays.

Nutrien's improvement plan in Brazil is on track, involving the idling of five blenders, closure of 54 unproductive locations, and a workforce reduction of 700 people, alongside a focus on credit collection. The Brazilian fertilizer market saw a 2% increase in volumes this year, with 47 million tonnes applied to farms. Brazilian farmers continue to prioritize yield maximization through appropriate application rates, with Nutrien and Canpotex being the largest supplier of potash into Brazil. Proprietary product growth in Brazil also remains a focus.